Development of an HPLC-UV assay method for the simultaneous quantification of nine antiretroviral agents in the plasma of HIV-infected patients
2016-01-01 Charbe, N; Baldelli, S; Cozzi, V; Castoldi, S; Cattaneo, D; Clementi, E
Transplacental passage of ritonavir-boosted darunavir in two pregnant women
2009-01-01 Ripamonti, D.; Cattaneo, D; Cortinovis, M.; Maggiolo, F.; Suter, F.
Linezolid for extensively drug-resistant tuberculosis
2013-01-01 Cattaneo, D; Orlando, G; Cordier, L
Passage of Venlafaxine in Human Milk During 12 Months of Lactation: A Case Report
2022-01-01 Baldelli, S; Pogliani, L; Schneider, L; Clementi, E; Zuccotti, G; Cattaneo, D
Optimizing Antibiotic Therapy for Intravenous Drug Users: A Narrative Review Unraveling Pharmacokinetics/Pharmacodynamics Challenges
In corso di stampa Colaneri, M; Genovese, C; Valsecchi, P; Calia, M; Cattaneo, D; Gori, A; Bruno, R; Seminari, E.
Omega-3 Polyunsaturated Fatty Acids Affect Sirolimus Exposure in Kidney Transplant Recipients on Calcineurin Inhibitor-Free Regimen
2010-01-01 Cortinovis, Monica; Gotti, Eliana; Remuzzi, Giuseppe; Perico, Norberto; Cattaneo, D; Baldelli, Sara
Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report
2022-01-01 Cheli, S; Cozzi, V; Cattaneo, D; Norsa, L; De Giacomo, C; Clementi, E; Moretti, C
Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events
2013-01-01 Gervasoni, C; Meraviglia, P; Landonio, S; Baldelli, S; Fucile, S; Castagnoli, L; Clementi, E; Riva, A; Galli, M; Rizzardini, G; Cattaneo, D
Pharmacokinetic drug evaluation of dolutegravir plus rilpivirine for the treatment of HIV
2017-01-01 Capetti, Af; Astuti, N; Cattaneo, D; Rizzardini, G
Lipid oxidative stress and the anti-inflammatory properties of statins and ACE inhibitors
2005-01-01 Cattaneo, D; Remuzzi, G
Management of Polypharmacy and Potential Drug-Drug Interactions in Patients with Pulmonary Aspergillosis: A 2-Year Study of a Multidisciplinary Outpatient Clinic
2024-01-01 Cattaneo, D; Torre, A; Schiuma, M; Civati, A; Casalini, G; Gori, A; Antinori, S; Gervasoni, C.
Drug-Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients
2021-01-01 Cattaneo, D; Pasina, L; Maggioni, Ap; Oreni, L; Conti, F; Pezzati, L; Casalini, G; Bonazzetti, C; Morena, V; Ridolfo, A; Antinori, S; Gervasoni, C.
Aldosterone and progression of kidney disease
2009-01-01 Cortinovis, Monica; Perico, Norberto; Cattaneo, D; Remuzzi, Giuseppe
Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic
2023-01-01 Cattaneo, Dario; Torre, Alessandro; Schiuma, Marco; Civati, Aurora; Lazzarin, Samuel; Rizzardini, Giuliano; Gori, Andrea; Antinori, Spinello; Gervasoni, Cristina
Do lopinavir and ritonavir require a dose adjustment during pregnancy?
2014-01-01 Ripamonti, D; Cattaneo, D
Atypical pharmacokinetics of atazanavir in an HIV-1-infected patient
2012-01-01 Cattaneo, D; Meraviglia, Paola; Cozzi, Valeria; Baldelli, Sara; Milani, Greta; Clementi, Emilio
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study
2021-01-01 Giacomelli, A; Pagani, G; Ridolfo, Al; Oreni, L; Conti, F; Pezzati, L; Bradanini L, ; Casalini, G; Bassoli, C; Morena, V; Passerini, S; Rizzardini, G; Cogliati, C; Ceriani, E; Colombo, R; Rusconi, S; Gervasoni, C; Cattaneo, D; Antinori, S; Galli, M.
Liver Injury After Occasional Energy Drink Use in a Patient Living With HIV and Diabetes
2020-01-01 Cattaneo, D; Riva, A; Filice, C; Gervasoni, C
Is there still room for therapeutic drug monitoring of linezolid in patients with tuberculosis?
2016-01-01 Cattaneo, D; Gervasoni, C; Clementi, E.
Darunavir does not prevent SARS-CoV-2 infection in HIV patients
2020-01-01 Riva, A; Conti, F; Bernacchia, D; Pezzati, L; Sollima, S; Merli, S; Siano, M; Lupo, A; Rusconi, S; Cattaneo, D; Gervasoni, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Development of an HPLC-UV assay method for the simultaneous quantification of nine antiretroviral agents in the plasma of HIV-infected patients | 1-gen-2016 | Charbe, N; Baldelli, S; Cozzi, V; Castoldi, S; Cattaneo, D; Clementi, E | |
| Transplacental passage of ritonavir-boosted darunavir in two pregnant women | 1-gen-2009 | Ripamonti, D.; Cattaneo, D; Cortinovis, M.; Maggiolo, F.; Suter, F. | |
| Linezolid for extensively drug-resistant tuberculosis | 1-gen-2013 | Cattaneo, D; Orlando, G; Cordier, L | |
| Passage of Venlafaxine in Human Milk During 12 Months of Lactation: A Case Report | 1-gen-2022 | Baldelli, S; Pogliani, L; Schneider, L; Clementi, E; Zuccotti, G; Cattaneo, D | |
| Optimizing Antibiotic Therapy for Intravenous Drug Users: A Narrative Review Unraveling Pharmacokinetics/Pharmacodynamics Challenges | In corso di stampa | Colaneri, M; Genovese, C; Valsecchi, P; Calia, M; Cattaneo, D; Gori, A; Bruno, R; Seminari, E. | |
| Omega-3 Polyunsaturated Fatty Acids Affect Sirolimus Exposure in Kidney Transplant Recipients on Calcineurin Inhibitor-Free Regimen | 1-gen-2010 | Cortinovis, Monica; Gotti, Eliana; Remuzzi, Giuseppe; Perico, Norberto; Cattaneo, D; Baldelli, Sara | |
| Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report | 1-gen-2022 | Cheli, S; Cozzi, V; Cattaneo, D; Norsa, L; De Giacomo, C; Clementi, E; Moretti, C | |
| Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events | 1-gen-2013 | Gervasoni, C; Meraviglia, P; Landonio, S; Baldelli, S; Fucile, S; Castagnoli, L; Clementi, E; Riva, A; Galli, M; Rizzardini, G; Cattaneo, D | |
| Pharmacokinetic drug evaluation of dolutegravir plus rilpivirine for the treatment of HIV | 1-gen-2017 | Capetti, Af; Astuti, N; Cattaneo, D; Rizzardini, G | |
| Lipid oxidative stress and the anti-inflammatory properties of statins and ACE inhibitors | 1-gen-2005 | Cattaneo, D; Remuzzi, G | |
| Management of Polypharmacy and Potential Drug-Drug Interactions in Patients with Pulmonary Aspergillosis: A 2-Year Study of a Multidisciplinary Outpatient Clinic | 1-gen-2024 | Cattaneo, D; Torre, A; Schiuma, M; Civati, A; Casalini, G; Gori, A; Antinori, S; Gervasoni, C. | |
| Drug-Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients | 1-gen-2021 | Cattaneo, D; Pasina, L; Maggioni, Ap; Oreni, L; Conti, F; Pezzati, L; Casalini, G; Bonazzetti, C; Morena, V; Ridolfo, A; Antinori, S; Gervasoni, C. | |
| Aldosterone and progression of kidney disease | 1-gen-2009 | Cortinovis, Monica; Perico, Norberto; Cattaneo, D; Remuzzi, Giuseppe | |
| Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic | 1-gen-2023 | Cattaneo, Dario; Torre, Alessandro; Schiuma, Marco; Civati, Aurora; Lazzarin, Samuel; Rizzardini, Giuliano; Gori, Andrea; Antinori, Spinello; Gervasoni, Cristina | |
| Do lopinavir and ritonavir require a dose adjustment during pregnancy? | 1-gen-2014 | Ripamonti, D; Cattaneo, D | |
| Atypical pharmacokinetics of atazanavir in an HIV-1-infected patient | 1-gen-2012 | Cattaneo, D; Meraviglia, Paola; Cozzi, Valeria; Baldelli, Sara; Milani, Greta; Clementi, Emilio | |
| Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study | 1-gen-2021 | Giacomelli, A; Pagani, G; Ridolfo, Al; Oreni, L; Conti, F; Pezzati, L; Bradanini L, ; Casalini, G; Bassoli, C; Morena, V; Passerini, S; Rizzardini, G; Cogliati, C; Ceriani, E; Colombo, R; Rusconi, S; Gervasoni, C; Cattaneo, D; Antinori, S; Galli, M. | |
| Liver Injury After Occasional Energy Drink Use in a Patient Living With HIV and Diabetes | 1-gen-2020 | Cattaneo, D; Riva, A; Filice, C; Gervasoni, C | |
| Is there still room for therapeutic drug monitoring of linezolid in patients with tuberculosis? | 1-gen-2016 | Cattaneo, D; Gervasoni, C; Clementi, E. | |
| Darunavir does not prevent SARS-CoV-2 infection in HIV patients | 1-gen-2020 | Riva, A; Conti, F; Bernacchia, D; Pezzati, L; Sollima, S; Merli, S; Siano, M; Lupo, A; Rusconi, S; Cattaneo, D; Gervasoni, C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26843
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269047
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS226
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE181
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19414
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19124
- ita408
- spa13
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24590
- reserved1362
- open891